Virica Biotech, an Ottawa-based medical sciences startup co-founded by Ella Korets-Smith, uses breakthrough tech to help improve disease-fighting gene therapies.
Internationally-recognized scientist Dr. Jean-Simon Diallo is infecting cancer cells with viruses with his team at Virica Biotech in groundbreaking cancer treatment.
While about three-quarters of Virica’s 50 customers are gene therapy producers, founder and CEO Jean-Simon Diallo says his firm’s technology also accelerates the production of
Ottawa startup announced this week it’s landed $400,000 in federal government funding to help the National Research Council of Canada develop a gene therapy to
Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.
Company’s revenues have more than doubled in the past year, and CEO expects headcount to grow from 16 to at least 30 by next year
Local economic development agencies are doing their best to help give the city’s fledgling biotech and medical devices sector a leg up